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ABSTRACT
Traumatic brain injury is the first cause of death and disability in children and young adults in 
worldwide. During the acute phase of recovery from moderate to severe brain injury, a period 
of post-traumatic confusion state (PTCS) will arise that is a combination of cognitive and 
behavioral dysfunction. Seven key symptoms of PTCS are identified and measured by Confusion 
Assessment Protocol (CAP). Agitation can be part of PTCS in the acute phase or, part of the 
recovery of consciousness in chronic phase. There are different hypothesis and classifications 
of acute and chronic post-traumatic aggressive syndromes. While post-traumatic aggression is 
common, its mechanism, assessment tool, outcome and treatment plans are not well-defined. 
Understanding the different aspects of post-traumatic aggression; mechanism, differential 
diagnosis, and treatment are reviewed in this article.
INTRODUCTION
Neurobehavioral consequences of traumatic brain injury (TBI) 
such as cognitive impairment, aggression, and emotional in-
stability are the most challenging burdens in the process of 
recovery with the poorest functional outcome and responsive-
ness to rehabilitation plans. During the acute phase of recovery 
from TBI, there is a period of post-traumatic confusion state 
(PTCS), previously called post-traumatic amnesia (PTA) (1) 
that is a combination of cognitive and behavioral disorders. It 
has been classified by Confusion Assessment Protocol (CAP) 
score with combination of 7 key symptoms as following: 1. dis-
orientation, 2. cognitive impairment, 3. fluctuation of presenta-
tion, 4. restlessness, 5. nighttime sleep disturbance, 6. daytime 
decreased arousal, and 7. psychotic type symptoms (2,3). Rest-
lessness and agitation are part of acute recovery that is defined 
as over-activity related to PTA (4).
During the later stages of recovery, when the patient is 
more cognitively aware and is no longer in the phase of PTA 
or PTCS (5) aggressive behavior can happen. Aggression 
at this stage is defined as verbal and physical aggression 
against objects, self, and the others (6). Aggression is also 
classified as severe irritability, violent behavior and episodic 
dyscontrol that is defined as goal directed aggression or ex-
plosive aggression (7).
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PREVALENCE AND PREDICTOR FACTORS
Prevalence of post-traumatic aggression in the acute phase 
is 35-96% and from 1 year to 15 years post-traumatic it is 
between 31 to 71% (5). Predictor factors of post-traumatic 
aggression has been discussed in previous studies that have 
been defined as pre-injury history of aggression, irritability 
and impulsivity, new onset of depression, alcohol abuse, in-
fection, epilepsy, metabolic disorders, impaired social inter-
action, frontal lobe lesion, orbitofrontal syndrome, anterior 
temporal lesion and increased dependence on activities of 
daily living (8,9).
Also, there are reports of correlations between the re-
sult of the neuropsychological tests and prediction of ag-
gression, e.g., Rancho Los Amigos Scale score (Confused, 
Agitated) was associated with acute post-traumatic agi-
tation, and lower Function independence measure (FIM) 
cognitive scores were associated with more severe agita-
tion (10,11).
Some medications can be associated with more severe 
agitation in the acute phase of recovery, e.g., anticonvulsants 
with sodium channel blockers activity, high potency sec-
ond-generation antipsychotics, gamma-aminobutyric acid-A 
(GABA-A) anxiolytics/hypnotics, alcohol, benzodiazepines, 
barbiturates, anticholinergic, and steroids (12).
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Some studies have found that patients with impulsive ag-
gression may have more severe cognitive dysfunction with 
deficits in executive functioning and impulse regulation (13). 
This finding can be explained by the study that has shown 
executive attention deficit as part of post-traumatic impaired 
attention may be the most common and debilitating cognitive 
deficit causing rehabilitation barriers and long-term disabil-
ity (13,14). Another study have found a significant associa-
tion between low satisfaction with life and aggression 6 and 
24 months post-TBI that can be due to the patient’s feeling 
of invasion to their personal space by their caregiver’s assis-
tance. Therefore, their resistance to any type of assistance can 
lead to some type of aggression and conflict or be as a result 
of post-traumatic depression and lack of motivation (15,16).
STRUCTURAL CHANGES, 
NEUROTRANSMITTER DYSREGULATION, AND 
ENVIRONMENTAL FACTORS
Post-traumatic cognitive and behavioral complexity are a 
cause for the existence of different hypotheses to find the 
main reason for aggression in some patients. Several struc-
tural lesions are considered as reasons for post-traumatic 
aggression such as orbitofrontal cortex, hippocampus, par-
ahippocampal gyrus, insula, temporal pole, olfactory cortex, 
cingulate cortex, amygdala, septal nuclei, hypothalamus, 
and select thalamic nuclei (17).
The prefrontal cortex is the center of executive cognitive 
functioning such as planning, initiative, and evaluation, and 
also regulation of behaviors and impulses (18). Studies have 
shown an association between decreased metabolism in the 
orbitofrontal cortex with increased aggression in patients 
with personality disorders (19). Disruption of orbitofrontal 
efferent projections to limbic structures may lead to dener-
vation hypersensitivity and limbic neural excitability which 
induces aggression (20,21). Lesions in this area could cause 
depression, withdrawal, general personality change, impul-
sivity, and persistent impulsive aggression, as well as perse-
veration, disinhibition, apathy, inattention, loss of memory, 
planning impairment, and problem-solving deficiency (22).
Also, some researchers hypothesize since the nature of 
most brain injuries is diffuse; lesions in frontotemporal, 
subcortical and brainstem areas may predispose patients to 
post-traumatic agitation (23). Frontotemporal, subcortical 
and brainstem coordinate arousal, attention, memory and 
limbic behavioral functions. Also, lesions in the frontotem-
poral area can cause seizure or subclinical epileptic focus 
that may manifest as dyscontrol syndrome with aggressive 
behaviors (24).
Another hypothesis for aggression is the lack of emo-
tional awareness as a requirement for conscious regulation 
of emotions (25). Without awareness, the patient will not 
be able to learn copying skills (26). While anger and emo-
tional dysregulation have been characterized as aggression, 
it can be referred to as alexithymia which is a combination 
of poor emotional awareness, difficulty processing physical 
sensations and self-reporting of their own emotion and a 
preference for discussing superficial facts rather than emo-
tion (27,43).
Hypothalamus controls flight or fight reaction by regulat-
ing autonomic and neuroendocrine responses,(8) and amyg-
dala in limbic system mediates impulses from the prefrontal 
cortex and hypothalamus and can regulate the emotional 
content of cognition so that any damage can lead to emo-
tional liability and impairment of impulse control (28,29).
Neuroimaging studies suggest that the cognitive process 
of labeling emotions helps down-regulate the emotional 
limbic reaction. (18-21) Therefore, people who have trou-
ble describing their emotions may have difficulty regulating 
unpleasant feelings. (40)
Several neurotransmitters such as serotonin, 5-hydroxy-
tryptamine (5Ht2), GABA, acetylcholine, norepinephrine, 
dopamine and monoamine oxidase inhibitor (MOI) are in-
volved with aggression (30-33). Cholinergic transmitters are 
more concentrated in the nucleus basalis of Meynert in the 
basal forebrain. Increased cholinergic activity may cause 
more neurotoxicity and aggression (34,35). An increase in 
their activity of serotonergic and catecholaminergic can re-
duce cerebral metabolism and affect as a neuroprotective 
that decrease in their activity is associated with impulsivity 
and aggression (35). Also, a reduction in the level of 5-hy-
droxy indoleacetic acid (5-HIAA) is associated with aggres-
sion (36). Dopaminergic transmitters are located at ventral 
tegmentum or substantia nigra and increased activity in do-
pamine and norepinephrine may be associated with aggres-
sion (37).
Environmental factors such as well-designed neuro-psy-
chotherapy and family relationship play an important role in 
functional and psychosocial outcomes of TBI, especially in 
the case of aggression and cognitive impairment (38).
TREATMENT PLANS
There are several recommendation plans to prevent and treat 
aggression that their effectiveness has not been studied in a 
large study population or clinical trials.
1. Anger management training and insight-oriented psy-
chotherapy will focus on increasing awareness of the 
cause of anger and symptom reduction (39).
2. Training caregivers to reduce environmental and in-
terpersonal factors that may trigger any misbehaviors 
such as aggression by using structured daily program, 
in-home cognitive and behavioral rehabilitation (41,42).
3. Medications that can decrease aggression have been 
reviewed, and there has been different results and rec-
ommendations either in the acute or chronic phase of 
post-traumatic aggression. Several various medications 
exist to achieve the following desired goals:
 a.  To inhibit the excessive activity of limbic: Anticon-
vulsant, noradrenergic blockade (propranolol), do-
paminergic (haloperidol).
 b.  Augmentation of orbitofrontal, dorsolateral pre-
frontal: Monoaminergic agonist (amantadine, 
methylphenidate, buspirone).
 c.  To increase serotonergic input: Selective serotonin 
reuptake inhibitor (SSRI)
Several studies have recommended using SSRIs as the 
first line of therapy along with adding an atypical antipsy-
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chotic. Some of the medications can lead to increased akathi-
sia or restlessness, cognitive impairment, longer PTA, mem-
ory dysfunction, the problem with coordination and balance 
and, therefore, should be avoided, e.g. benzodiazepines and 
haloperidol. (44-46)
List of the medications that can be used in the chronic 
phase of aggression is provided as buspirone, clonazepam, 
carbamazepine, valproic acid, lamotrigine, oxcarbazepine, 
lithium, TCA (amitryptiline), SSRI (Trazadone, Fluoxetine, 
sertraline, citalopram), beta blockers, amantadine, and meth-
ylphenidate (6,43).
CONCLUSION
Cognitive and behavior disorders after TBI can be very 
challenging and disruptive in the process of recovery and 
rehabilitation. Lack of evidence-based practices and clini-
cal trials in this field is alarming. A multi-disciplinary and 
timely manner approach can change the outcome and im-
prove understanding the mechanism and effectiveness of 
treatment plans. While there are several recommendations 
to manage post-traumatic aggression, a well-organized and 
standard plan for monitoring and measuring the outcome is 
missing.
First, assessment of the aggression and its risk factors 
during its acute phase of onset should be considered with a 
plan to reduce the environmental factors, training caregiv-
ers and using the right medication based on patients’ back-
ground and structural lesions and physiological condition.
Second, the patient should be monitored during recovery 
from the acute to chronic phase by psychological assessment 
test, imaging, electroencephalogram biomarkers to adjust 
the treatment plan accordingly.
A multi-disciplinary approach and providing a holis-
tic neuro rehabilitation plan will cause a better outcome in 
post-traumatic aggression.
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